StockData
Adaptimmune Therapeutics PLC logo

Adaptimmune Therapeutics PLC (ADAPY) stock

ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2025, quarter ended Jun 30, 2025Last filing: 10-Q on Aug 13, 2025Score 3/30
$0.04+0.00 (+9.38%)

Close on Oct 19, 2026Market cap $55.46MP/E –Yield –

Adaptimmune Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Adaptimmune Therapeutics's price to book ratio was 35.9× on Apr 30, 2025, against 41.0× a year earlier. Over the last 5 years it ranged from 5.8× to 83.6×, with a median of 14.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202535.9×+25.6
2024Dec 31, 202410.3×−1.9
2023Dec 29, 202312.3×−0.4
2022Dec 30, 202212.7×−1.9
2021Dec 31, 202114.6×+1.3
2020Dec 31, 202013.3×+8.2
2019Dec 31, 20195.1×−30.1
2018Apr 30, 201835.2×+18.8
2017Dec 29, 201716.4×+9.8
2016Dec 30, 20166.6×−13.1
2015Dec 31, 201519.8×–

More Adaptimmune Therapeutics figures

See a number that looks wrong?